| Basics |
Natera, Inc.
Natera Inc is a provider of diagnostic services predominantly in the United States. It offers various tests which detect chromosomal abnormalities, reasons for miscarriages and paternity.
|
| IPO Date: |
July 2, 2015 |
| Sector: |
Healthcare |
| Industry: |
Medical Diagnostics and Research |
| Market Cap: |
$25.65B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.24 | 2.45%
|
| Avg Daily Range (30 D): |
$2.83 | 1.63%
|
| Avg Daily Range (90 D): |
$2.81 | 1.74%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.74M |
| Avg Daily Volume (30 D): |
.85M |
| Avg Daily Volume (90 D): |
1.04M |
| Trade Size |
| Avg Trade Size (Sh.): |
64 |
| Avg Trade Size (Sh.) (30 D): |
38 |
| Avg Trade Size (Sh.) (90 D): |
41 |
| Institutional Trades |
| Total Inst.Trades: |
6,948 |
| Avg Inst. Trade: |
$5.03M |
| Avg Inst. Trade (30 D): |
$19.06M |
| Avg Inst. Trade (90 D): |
$12.43M |
| Avg Inst. Trade Volume: |
.06M |
| Avg Inst. Trades (Per Day): |
3 |
| Market Closing Trades |
| Avg Closing Trade: |
$10.07M |
| Avg Closing Trade (30 D): |
$36.15M |
| Avg Closing Trade (90 D): |
$28.37M |
| Avg Closing Volume: |
126.47K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$-1.91
|
$-.74
|
$-.5
|
|
Diluted EPS
|
$-1.91
|
$-.74
|
$-.5
|
|
Revenue
|
$ 1.96B
|
$ 546.6M
|
$ 501.83M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -253.24M
|
$ -100.94M
|
$ -66.94M
|
|
Operating Income / Loss
|
$ -293.63M
|
$ -110.37M
|
$ -79.18M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ 203.22M
|
$ 26.25M
|
$ 28.18M
|
|
PE Ratio
|
|
|
|
|
|
|
